Evidence map›Paper›PMID 42807410›Full record

ReviewFrontiers in immunology2026

Research progress on the relationship between the TdT gene and autoimmune diseases.

Yangyang Man, Xueli Yang, Xiaoni Chen, Yi Liu, Jiahua Hu, Shaofeng Jiang, Xianliang Hou

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yangyang Man *Laboratory Center, Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Xueli Yang *Laboratory Center, Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Xiaoni Chen *Department of Central Laboratory, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong, China.
Yi LiuLaboratory Center, Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Jiahua HuDepartment of Central Laboratory, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong, China.
Shaofeng JiangGuangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, School of Basic Medicine Sciences, Guilin Medical University, Guilin, China.
Xianliang HouLaboratory Center, Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune diseases (AIDs) are caused by defects in immune tolerance or abnormalities in immune regulation, leading to damage to host organs. The pathogenesis of AIDs is complex, and their clinical manifestations are diverse. Currently, the pathogenesis of AIDs is not fully understood. Accumulating evidence from experimental models suggests that TdT-mediated antigen receptor diversification may influence autoimmune responses and immune regulation. Although emerging evidence from human autoimmune diseases has been reported, the current understanding of the relationship between TdT and AIDs remains limited. Understanding the mechanisms by which TdT influences autoimmune responses may provide new insights into disease pathogenesis and future therapeutic exploration. This review summarizes relevant information on the TdT gene and discusses current evidence regarding the relationship between TdT and AIDs, with particular emphasis on findings from experimental models and emerging evidence from human autoimmune diseases.

Indexed as

Autoimmune DiseasesAnimalsAutoimmunityGenetic Predisposition to DiseaseHumansImmune Toleranceautoimmune diseasesimmune toleranceimmunityTdT geneV(D)J recombination

Identifiers

PMID42807410
PMCPMC13617742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.